Fact based stock research
Biotest (DB:BIO3)


Biotest stock research in summary

biotest.de


Biotest stock research analysis by the purely financial fact-based Obermatt method on current and historical performance by investment strategy | Biotest (DB:BIO3), Biotechnology, Germany


Latest Obermatt Ranks


Country Germany
Industry Biotechnology
Index CDAX, SDAX
Size class Small

January 25, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Gold Winner CEO

Top 10 Stock



Research History: Biotest

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
39
46
36
37
STOCK GROWTH RANKS
5
58
STOCK SAFETY RANKS
48
44
COMBINED STOCK RANKS
8
49
13

Last update of Combined Rank: 6-Apr-2017. Stock research history is based on the Obermatt Method. The higher the rank, the better is Biotest in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 25-Jan-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Biotest; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

Financial reporting date of Growth Rank: 31-Dec-2016. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Biotest.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
19
14
REFINANCING
85
84
LIQUIDITY
33
30
CONSOLIDATED RANK: SAFETY
48
44

Financial reporting date of Safety Rank: 31-Dec-2016. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Biotest and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Biotest from January 25, 2018.